Grace Colón

Grace Colón

Directeur/Membre du Conseil chez VOYAGER THERAPEUTICS, INC.

Fortune : 308 441 $ au 31/05/2024

57 ans
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Grace E.
Colón
is a Chairman at Bloom Science, Inc., an Independent Director at Voyager Therapeutics, Inc., an Executive Chairman at ProterixBio, Inc., a Member at Latino Corporate Directors Association and a Member at Women Corporate Directors.
She is on the Board of Directors at Voyager Therapeutics, Inc., Biotechnology Innovation Organization, MIT Corp.
(United States) and Massachusetts Institute of Technology.
Dr. Colón was previously employed as an Independent Director by CareDx, Inc., a Partner by New Science Ventures LLC, a Co-Founder by Pyranose Biotherapeutics, a President, Chief Executive Officer & Director by InCarda Therapeutics, Inc., a Head-Clinical Operations by Gilead Sciences /Oncology Operations/, a President-Industrial Products Division & SVP by Intrexon Corp., a Chief Operating Officer by International Genomics Consortium, a Vice President-Corporate Planning by Affymetrix, Inc., and an Engagement Manager by McKinsey & Co., Inc. She also served on the board at Paradigm Diagnostics, Inc., Cocoon Biotech, Inc. and PerceptiMed, Inc. She received her undergraduate degree from the University of Pennsylvania and a doctorate degree from the University of Massachusetts.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2024 23 708 ( 0,05% ) 308 441 $ 31/05/2024
05/06/2024 0 ( -.--% ) - $ 31/05/2024

Postes actifs de Grace Colón

SociétésPosteDébut
VOYAGER THERAPEUTICS, INC. Directeur/Membre du Conseil 01/01/2023
Massachusetts Institute of Technology Directeur/Membre du Conseil -
Corporate Officer/Principal -
Corporate Officer/Principal -
Président 17/05/2023
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Président 01/11/2016
Tous les postes actifs de Grace Colón

Anciens postes connus de Grace Colón

SociétésPosteFin
CAREDX, INC Directeur/Membre du Conseil 13/06/2024
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Grace Colón

Formation de Grace Colón

University of Pennsylvania Undergraduate Degree
University of Massachusetts Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Grace Colón

Relations

100 +

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
CAREDX, INC

Health Technology

PRECIGEN, INC.

Health Technology

VOYAGER THERAPEUTICS, INC.

Health Technology

Entreprise privées16

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Gilead Sciences /Oncology Operations/

Health Technology

Finance

International Genomics Consortium

Commercial Services

Health Technology

Commercial Services

Consumer Services

Technology Services

Pyranose Biotherapeutics

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Grace Colón